По вашему запросу найдено документов: 137

Страница 8 из 14

used in the clinic although they cause several severe side effects and accumulate in tissues. Therefore

with properly assessment of clinical and laboratorial findings.

ГЕНЕТИЧЕСКИЕ МАРКЕРЫ ОСТЕОАРТРИТА У ЖЕНЩИН С НЕДИФФЕРЕНЦИРОВАННОЙ ДИСПЛАЗИЕЙ СОЕДИНИТЕЛЬНОЙ ТКАНИ). On the basis of clinical and genetic data, we revealed statistically significant models to predict

in two unrelated families. Clinical studies have shown that, in both families, the disease corresponds

pathogenesis and discussed their potential clinical application as non-invasive biomarkers.

, the persisting deficiencies and future prospects of using lncRNAs as clinical biomarkers and therapeutic targets

similar clinical picture is emphasized.

clinically significant microorganisms: Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa

, and Australia. Clinical trial and registry data were included. Primary end points were progression-free survival

to estimate prognosis of STEMI patients have been proposed and their potential clinical impact requires

Страница 8 из 14